sapropterin dihydrochloride

FDA Drug Profile — sapropterin dihydrochloride, ZELVYSIA, Kuvan

sapropterin dihydrochloride is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including sapropterin dihydrochloride, ZELVYSIA, Kuvan. Available dosage forms: tablet, powder, for solution.

Drug details

Generic Name
sapropterin dihydrochloride
Brand Names
sapropterin dihydrochloride, ZELVYSIA, Kuvan
Application Number
ANDA215534
Sponsor
Camber Pharmaceuticals, Inc.
NDC Codes
7
Dosage Forms
TABLET, POWDER, FOR SOLUTION
Routes
ORAL
Active Ingredients
SAPROPTERIN DIHYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Sapropterin dihydrochloride tablets are indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). Sapropterin dihydrochloride tablets are to be used in conjunction with a Phe- restricted diet. Sapropterin dihydrochloride tablets are a phenylalanine hydroxylase activator indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). Sapropterin dihydrochloride tablets are to be used in conjunction with a Phe-restricted diet. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.